Amarin Corporation plc (AMRN) Financials

AMRN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 645.8 million 196.4 million
Dec. 31, 2025 670.8 million 211.5 million
Sept. 30, 2025 659.8 million 200.9 million
June 30, 2025 670.1 million 205.2 million

AMRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 6.4 million 2.3 million
Dec. 31, 2025 15.3 million -12.3 million
Sept. 30, 2025 -12.8 million 2.0 million
June 30, 2025 16.6 million 6.0 million

AMRN Net Income

No data available :(

AMRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 307.8 million 5.6 million 5.6 million
Dec. 31, 2025 302.8 million 6.1 million 6.1 million
Sept. 30, 2025 286.6 million 6.7 million 6.7 million
June 30, 2025 298.7 million - 7.3 million

AMRN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 20.8 million
Dec. 31, 2025 20.8 million
Sept. 30, 2025 20.8 million
June 30, 2025 20.7 million

AMRN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3 4.7 million 21.1 million 3.9 million
Dec. 31, 2025 - 4.7 million 20.0 million -
Sept. 30, 2025 4 4.2 million 19.7 million 5.4 million
June 30, 2025 - 4.9 million 38.7 million 14.6 million

AMRN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 43.3 million 25.6 million
Dec. 31, 2025 49.1 million 26.7 million
Sept. 30, 2025 49.7 million 27.5 million
June 30, 2025 72.7 million 22.4 million

AMRN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AMRN

Price: $13.80

52 week price:
9.98
20.90

Earnings Per Share: -1.60 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Ireland

Volume: 2.2 million

Ebitda: -8.2 million

Market Capitalization: 304.9 million

Links: